Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions

The Pharmacogenomics Journal volume 11, pages 45–52 (2011)Cite this article

Subjects

Abstract

In prior studies we found that young, female smokers manifest poorer performance than non-smokers on attention-related tasks and that these findings can be moderated by variation in nicotinic acetylcholine receptor (nAChR) genes. We predicted that under controlled conditions (1) nicotine would improve functioning on attentional tasks in smokers who previously manifested relatively poor performance, and that (2) smokers who carry genetic variations associated with poorer attention performance would derive greater benefit from nicotine. To test these hypotheses, 31 young female smokers, who participated in our previous study, performed the Matching Familiar Figures Test (MFFT), Tower of London Test and Continuous Performance Task (CPT) in a double-blind, within-between subject design, placebo or nicotine (4 mg as gum) serving as the within factor and genetic profile as the between factor. Repeated measures ANCOVA controlling for attention deficit symptomatology, substance abuse and nicotine dependence showed better performance under nicotine among participants with higher levels of attention deficit symptoms (MFFT errors: P=0.04; CPT commissions: P=0.01) and nicotine dependence (CPT stability of response: P=0.04) and greater consumption of caffeine (CPT stability of response: P=0.04). An interactive effect of genetic profile was demonstrated for SNP rs2337980 in CHRNA7. These findings suggest that nicotine may have stronger short-term facilitating effects on attention in women who have more attention deficit symptoms and consume more nicotine and caffeine. This effect may be modified by a specific genetic make-up. Such individuals may be at increased risk for nicotine addiction and for greater difficulties in smoking cessation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Anderson P . Global use of alcohol, drugs and tobacco. Drug Alcohol Rev 2006; 25: 489–502.

    Article  Google Scholar 

  2. World Health Organization. Report on the Global Tobacco Epidemic, 2008—the Mpower Package. World Health Organization: Geneva, Switzerland. (Available from: http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=93&codcch=220)

  3. Israel Ministry of Health. Minister of Health Report About Smoking in Israel. Israel Ministry of Health: Jerusalem, Israel, 2007–2008. (Available from: http://www.health.gov.il/download/pages/smoke18052009.pdf (Hebrew))

  4. US Centers for Disease Control and Prevention. Global Youth Tobacco Survey. US Centers for Disease Control and Prevention (CDC): Atlanta, GA, 2007. (Available from: http://www.cdc.gov/Tobacco/global/gyts/)

  5. Payne S . Gender in Lung Cancer and Smoking Research. World Health Organization, Department of Gender, Women, Health Family and Community Health, 2005. (Available from: http://www.who.int/gender/documents/LungCancerlast2.pdf)

  6. Israel Ministry of Health. Minister of Health Report About Smoking in Israel. Israel Ministry of Health: Jerusalem, Israel, 2004–2005. (Available from: http://www.health.gov.il/download/forms/a2752_ALL_310705.pdf (Hebrew))

  7. Israel Ministry of Health. Minister of Health Report About Smoking in Israel. Israel Ministry of Health: Jerusalem, Israel, 2002–2003. (Available from: http://www.health.gov.il/Download/pages/isun2003.pdf (Hebrew))

  8. Greenbaum L, Kanyas K, Karni O, Merbl Y, Olender T, Horowitz A et al. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry 2006; 11: 312–322.

    Article  CAS  Google Scholar 

  9. Lerer E, Kanyas K, Karni O, Ebstein R, Lerer B . Why do young women moke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol Psychiatry 2006; 11: 771–781.

    Article  CAS  Google Scholar 

  10. Yakir A, Rigbi A, Kanyas K, Pollak Y, Kahana G, Karni O et al. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur Neuropsychopharmacol 2007; 17: 339–351.

    Article  CAS  Google Scholar 

  11. Segman R, Kanyas K, Karni O, Lerer E, Goltser-Dubner T, Pavlov V et al. Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience. Am J Med Genet B 2007; 144B: 533–540.

    Article  CAS  Google Scholar 

  12. Rigbi A, Kanyas K, Yakir A, Greenbaum L, Pollak Y, Ben-Asher E et al. Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes Brain Behav 2008; 7: 164–172.

    Article  CAS  Google Scholar 

  13. Heishman SJ, Taylor RC, Hennigfield JE . Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharmacol 1994; 2: 345–395.

    Article  CAS  Google Scholar 

  14. Heishman SJ . What aspects of human performance are truly enhanced by nicotine. Addiction 1998; 93: 317–320.

    Article  CAS  Google Scholar 

  15. Levin DL, McClernon FG, Rezvani AH . Nicotine effects on cognitive function: behavioral characterization, pharmacological specification and anatomic localization. Psychopharmacology 2006; 184: 523–539.

    Article  CAS  Google Scholar 

  16. Newhouse PA, Potter A, Singh A . Effects of nicotine stimulation on cognitive performance. Curr Opin Pharmacol 2004; 4: 36–46.

    Article  CAS  Google Scholar 

  17. Sherwood N . Effects of nicotine on human psychomotor performance. Hum Psychopharmacol 1993; 8: 155–184.

    Article  CAS  Google Scholar 

  18. Cincotta SL, Yorek MS, Moschak TM, Lewis SR, Rodefer JS . Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction. Curr Opin Investig Drugs 2008; 9: 47–56.

    CAS  PubMed  Google Scholar 

  19. Forgacs PB, Bodis-Wollner I . Nicotinic receptors and cognition in Parkinson's disease: the importance of neuronal synchrony. J Neural Transm 2004; 111: 1317–1331.

    Article  CAS  Google Scholar 

  20. Ochoa EL, Lasalde-Dominicci J . Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking. Cell Mol Neurobiol 2007; 27: 609–639.

    Article  CAS  Google Scholar 

  21. Sacco KA, Bannon KL, George TP . Nicotine receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 2004; 18: 457–474.

    Article  CAS  Google Scholar 

  22. Wilens TE, Decker MW . Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol 2007; 74: 1212–1223.

    Article  CAS  Google Scholar 

  23. Kumari V, Postma P . Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 2005; 29: 1021–1034.

    Article  CAS  Google Scholar 

  24. Potter AS, Newhouse PA, Bucci DJ . Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder? Behav Brain Res 200615; 175: 201–211.

    Article  CAS  Google Scholar 

  25. Mansvelder HD, van Aerde KI, Couey JJ, Brussaard AB . Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology 2006; 184: 292–305.

    Article  CAS  Google Scholar 

  26. Portugal GS, Gould TJ . Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. Behav Brain Res 2008; 193: 1–16.

    Article  CAS  Google Scholar 

  27. Espeseth T, Endestad T, Rootwelt H, Reinvang I . Nicotine receptor gene CHRNA4 modulates early event-related potentials in auditory and visual oddball target detection tasks. Neuroscience 2007; 147: 974–985.

    Article  CAS  Google Scholar 

  28. Espeseth T, Greenwood PM, Reinvang I, Fjell AM, Walhovd KB, Westlye LT et al. Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cogn Affect Behav Neurosci 2006; 6: 31–43.

    Article  Google Scholar 

  29. Greenwood PM, Fossella JA, Parasuraman R . Specificity of the effect of a nicotinic receptor polymorphism on individual differences in visuospatial attention. J Cogn Neurosci 2005; 17: 1611–1620.

    Article  Google Scholar 

  30. Parasuraman R, Greenwood PM, Kumar R, Fossella J . Beyond heritability: neurotransmitter genes differentially modulate visuospatial attention and working memory. Psychol Sci 2005; 16: 200–207.

    Article  Google Scholar 

  31. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86: 1119–1127.

    Article  CAS  Google Scholar 

  32. Kertzman S, Ben-Nahum Z, Sirota A . CogScan V4.0—Cognitive Scanning System. System Description. AnimaScan Ltd: Ashdod, Israel, 2003.

    Google Scholar 

  33. Brown TE . Brown Attention-Deficit Disorder Scales Manual. The Psychological Corporation: San Antonio, TX, 1996.

    Google Scholar 

  34. Murphy KR, Adler LA . Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiatry 2004; 65 (Suppl 3): 12–17.

    PubMed  Google Scholar 

  35. Barratt E . Barratt impulsiveness scale, version 11 (BSI-11). J Clin Psychol 1995; 51: 768–774.

    Article  Google Scholar 

  36. Benowitz NL . Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008; 83: 531–541.

    Article  CAS  Google Scholar 

  37. Hukkanen J, Peyton III J, Benowitz NL . Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005; 57: 79–155.

    Article  CAS  Google Scholar 

  38. Russel MAH . Nicotine intake by smokers: are rates of absorption or steady state levels more important?. In: Rand MJ, Thurau K (eds). The Pharmacology of Nicotine. IRL press: Oxford, UK, 1987, pp 375–402.

    Google Scholar 

  39. Kline P . An Easy Guide to Factor Analysis. Routledge: New York, NY, 1993.

    Google Scholar 

  40. Kollins SH, McClernon FJ, Fuemmeler BF . Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry 2005; 62: 1142–1147.

    Article  Google Scholar 

  41. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS . Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995; 7: 373–378.

    Article  CAS  Google Scholar 

  42. McClernon FJ, Kollins SH . ADHD and smoking: from genes to brain to behavior. Ann N Y Acad Sci 2008; 1141: 131–147.

    Article  CAS  Google Scholar 

  43. Cauli O, Morelli M . Caffeine and the dopaminergic system. Behav Pharmacol 2005; 16: 63–77.

    Article  CAS  Google Scholar 

  44. Swanson JA, Lee JW, Hopp JW . Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict Behav 1994; 19: 229–256.

    Article  CAS  Google Scholar 

  45. Riccio CA, Waldrop JJ, Reynolds CR, Lowe P . Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 2001; 13: 326–335.

    Article  CAS  Google Scholar 

  46. Tucha O, Lange KW . Effects of nicotine chewing gum on a real-life motor task: a kinematic analysis of handwriting movements in smokers and non-smokers. Psychopharmacology (Berl) 2004; 173: 49–56.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a grant from the Professor Milton Rosenbaum Endowment Fund for Research in the Psychiatric Sciences (to YP).

Author information

Authors and Affiliations

  1. Department of Psychiatry, Biological Psychiatry Laboratory, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

    A Rigbi, A Yakir, K Sarner-Kanyas & B Lerer

  2. Department of Psychology, Hebrew University, Jerusalem, Israel

    Y Pollak

Authors
  1. A Rigbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Yakir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Sarner-Kanyas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Pollak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Lerer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B Lerer.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rigbi, A., Yakir, A., Sarner-Kanyas, K. et al. Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions. Pharmacogenomics J 11, 45–52 (2011). https://doi.org/10.1038/tpj.2010.15

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2010.15

Keywords

This article is cited by

Search

Advanced search

Quick links